Month: March 2023

March 15, 2023News release BioPorto Provides a Business Update COPENHAGEN, DENMARK and BOSTON, MA, March 15, 2023, (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto or Company) (CPH:BIOPOR) today provided a business update. Preliminary key 2022 Financial ResultsRevenue for the full year 2022 is expected to be approximately DKK 29.0 million, which represents a 19% increase over the prior year and exceeds the upper end of the Company’s most recent guidance by 7%. Cash and cash equivalents are estimated to be approximately DKK 81.1 million as of December 31, 2022. These amounts are unaudited and preliminary. They also are subject to the Company’s management completing its customary procedures for finalizing the Annual Report and the Company’s independent auditor completing the year-end audit for 2022, among other factors. The Annual Report for 2022...

Toll Brothers at Verdier Pointe will open for sale in late summer 2023Toll Brothers at Verdier Pointe Toll Brothers at Verdier Pointe community of luxury homes is coming soon to Charleston, South CarolinaToll Brothers at Verdier Pointe “With floor plans designed for today’s home buyers and unrivaled personalization options available, Toll Brothers at Verdier Pointe will offer residents the best in luxury low-maintenance living in one of Charleston’s most desirable areas,” said Jason Simpson, Division President of Toll Brothers in South Carolina.CHARLESTON, S.C., March 15, 2023 (GLOBE NEWSWIRE) — Toll Brothers, Inc (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest community of luxury homes, Toll Brothers at Verdier Pointe, is coming soon to the desirable West Ashley area of Charleston,...

The Minister of Finance and Economic Affairs tasks the Central Bank of Iceland’s Government Debt Management department with concluding agreements on issuance of Treasury securities and market making in the secondary market. Resident entities that have an operating licence in accordance with Article 4, Paragraph 1 of the Act on Financial Undertakings, no. 161/2002, that have the equipment needed to participate in Treasury securities auctions and can demonstrate a secure settlement of transactions through the Central Bank of Iceland, may request to be parties to the agreement. Primary dealers have the exclusive right to submit bids at auctions where benchmark Treasury securities are offered for purchase or sale. They also receive access to special facilities such as repurchase agreements for Treasury securities, in accordance with the relevant...

HICKSVILLE, NY, March 15, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products and durable medical devices, is pleased to announce it has successfully completed a corporate debt restructuring. Through the restructuring, Can B raised $1.55 million of new capital and extended previously due notes payable totaling $7.0 million to September 1, 2023, and December 31, 2024.  Specifically, three Promissory Notes issued to three funds in early 2022 and three Promissory Notes issued to three private investors in late 2022 were restructured to extend maturity dates to late in 2023 to give the Company an additional window to deploy the capital from the new raise. The implementation...

Martinsried/Munich, March 15, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an early-stage immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, will report financial results and provide a corporate update for the fiscal year ended December 31, 2022 on Wednesday, March 29, 2023. Following the release of the full year 2022 financial results on Medigene’s website, the company will host a conference call that same day at 3 p.m. CET (9 a.m. ET). Full details for the conference call and webcast are as follows:Date March 29, 2023Time 3:00 p.m. CET (9 a.m. ET)U.S. Dial-in Number: +1 877-451-6152Int’l Dial-in Number: +1 201-389-0879Conference ID: 13736670Webcast: Join the live webcast here or at https://www.medigene.com/investors-media/reports-presentationsPlease...